ArticleJournal of nanobiotechnology2026
Polystyrene nanoplastics induce hepatic steatosis by disrupting autophagic degradation of NCoR1 and suppressing PPARα-mediated fatty acid oxidation.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Developmental Environmental Chronotoxicity by Polystyrene Nanoplastics Exacerbates High-Fat Diet-Induced Pediatric MAFLD Through Circadian Disruption and Mitochondrial Dysfunction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Micro- and nanoplastic (MNP) pollution is a global public health concern, with inevitable ingestion by humans. The liver functions as a primary target organ, and studies have confirmed the presence of microplastics in human hepatic tissues. However, the hepatotoxic effects resulting from such exposure remain poorly characterized. Although polystyrene nanoplastics (PSNPs) have been implicated in disrupting hepatic lipid homeostasis and inducing steatosis, the underlying molecular mechanisms remain elusive. In this study, C57BL/6J mice were gavaged with PSNPs to establish an in vivo exposure model. Histopathological analysis demonstrated that exposure to PSNPs, in conjunction with a high-fat diet (HFD), facilitated the development of a hepatic steatotic phenotype. Multi-omics analysis revealed significant suppression of the PPARα signaling pathway, mechanistically linked to impaired fatty acid β-oxidation. Further experiments demonstrated that PSNPs inhibited the autophagic degradation of NCoR1. Concurrently, PSNP exposure activated the mTOR/S6K2 signaling pathway, promoting NCoR1 phosphorylation and nuclear translocation, thereby suppressing PPARα-regulated expression of genes involved in fatty acid β-oxidation, ultimately leading to hepatic lipid accumulation. Overall, this study elucidates the molecular mechanism by which PSNPs induce hepatic steatosis through NCoR1 dysregulation, providing a theoretical foundation for nanoplastic-related hepatotoxicity research and advancing health risk assessment related to MNP pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.